Kutjevo d.d. (ZSE:KTJV)

Verve Therapeutics Revenue

Kutjevo d.d. had revenue of 11.97M EUR in the quarter ending March 31, 2025, with 21.28% growth. This brings the company's revenue in the last twelve months to 45.13M, down -5.69% year-over-year. In the year 2024, Kutjevo d.d. had annual revenue of 43.03M, down -10.23%.

• Revenue (ttm): 45.13M EUR
• Revenue Growth: -5.69%
• P/S Ratio: 0.81
• Revenue / Employee: 73.39K EUR
• Employees: 615
• Market Cap: 312.09M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.03M	-4.91M	-10.23%
Dec 31, 2023	47.94M	-4.25M	-8.15%
Dec 31, 2022	52.19M	5.65M	12.13%
Dec 31, 2021	46.54M	7.48M	19.14%
Dec 31, 2020	39.07M	-673.14K	-1.69%